Stero Therapeutics

Stero Biotechs is a clinical-stage biotechnology company based in Israel that specializes in the development of cannabidiol (CBD) based formulations designed to enhance the therapeutic efficacy of steroid treatments. The company's core strategy focuses on a "steroid-sparing" approach, utilizing CBD to reduce the required dosage of corticosteroids, thereby minimizing severe side effects while maintaining or improving clinical outcomes. Their lead programs target inflammatory and autoimmune conditions, including Graft-versus-Host Disease (GvHD) and Crohn's disease. Stero Biotechs has also conducted clinical trials exploring the use of its CBD-steroid combination to treat severe respiratory distress in COVID-19 patients. The company holds a robust portfolio of patents covering the synergistic use of cannabinoids and steroids across over 130 medical indications.